Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome: Analysis of EMPA-REG OUTCOME using REDUCE-IT criteria

OBJECTIVES: REDUCE-IT showed that icosapent ethyl (IPE) improved cardiovascular (CV) outcomes in participants with established CV disease (CVD) or type 2 diabetes (T2D) and at least one additional risk factor plus mild-moderate hypertriglyceridemia and reasonably controlled low-density lipoprotein c...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Subodh, Kosmopoulos, Andrew, Bhatt, Deepak L., Fitchett, David, Ofstad, Anne Pernille, Wanner, Christoph, Mattheus, Michaela, Zinman, Bernard, Lawler, Patrick R., Leiter, Lawrence A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293663/
https://www.ncbi.nlm.nih.gov/pubmed/37384110
http://dx.doi.org/10.1016/j.ajpc.2023.100510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293663/
https://www.ncbi.nlm.nih.gov/pubmed/37384110
http://dx.doi.org/10.1016/j.ajpc.2023.100510

Ejemplares similares